2024 年公司实现收入13.46 亿(+23.1%),归母净利润2.74 亿(+50.4%)。在集采推动下,人工关节行业进一步加速进口替代,公司产品的手术量需求持续增长,并提升医院覆盖率,也使得带量内产品销售进一步增长。同时,公司通过积极的市场开拓,以及在数字骨科全流程解决方案的带动下,海外手术量提升,海外收入获得显著增长。业绩的强劲复苏主要是由于收入增长以及费用管控。髋膝关节进口替代成效显著,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.